Does GLATIRAMER Cause Injection site discolouration? 270 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 270 reports of Injection site discolouration have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 0.6% of all adverse event reports for GLATIRAMER.
270
Reports of Injection site discolouration with GLATIRAMER
0.6%
of all GLATIRAMER reports
0
Deaths
16
Hospitalizations
How Dangerous Is Injection site discolouration From GLATIRAMER?
Of the 270 reports, 16 (5.9%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Injection site discolouration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 270 reports have been filed with the FAERS database.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site mass (2,172)
Injection site swelling (1,836)
What Other Drugs Cause Injection site discolouration?
ETANERCEPT (1,846)
DUPILUMAB (779)
CERTOLIZUMAB PEGOL (597)
ADALIMUMAB (554)
EVOLOCUMAB (476)
EXENATIDE (266)
TERIPARATIDE (249)
ASFOTASE ALFA (243)
ENBREL (231)
INSULIN GLARGINE (169)
Which GLATIRAMER Alternatives Have Lower Injection site discolouration Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE